Images List Premium Download Classic

Platelet

Platelet-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Piezoresistive device
Haydale Graphene Industries Plc
December 07, 2017 - N°20170350772

The present invention relates to piezoresistive devices and pressure sensors incorporating such devices. At its most general, the invention provides a piezoresistive device, comprising a piezoresistive material positioned between an upper conductive layer and a lower conductive layer, wherein the piezoresistive material comprises carbon nanoparticles (most preferably graphene nanoplatelets, graphene or carbon nanotubes) dispersed in a polymer matrix material. The ...
Method for producing anisotropic zinc phosphate particles and zinc metal mixed phosphate particles and use ...
Leibniz-institut Für Neue Materialien Gemeinnützige Gmbh
December 07, 2017 - N°20170349764

Anisotropic zinc phosphate particles and zinc metal mixed phosphate particles having an orthorhombic crystal structure and a platelet-shaped particle morphology are obtained from a composition comprising at least one phosphate compound; at least one zinc compound and at least one chelate complexing agent having at least two oxygen-containing groups and at least one solvent.
Effect pigments having high transparency, high chroma and high brilliancy, method for the production and ...
Eckart Gmbh
December 07, 2017 - N°20170349756

The invention relates to a transparent effect pigment which includes a non-metallic platelet-shaped substrate and a coating applied thereto, wherein the coating has a spacer layer. The invention further relates to a method for the production, as well as the use, of the transparent effect pigment.
Platelet Patent Pack
Download 244+ patent application PDFs
Platelet Patent Applications
Download 244+ Platelet-related PDFs
For professional research & prior art discovery
inventor
  • 244+ full patent PDF documents of Platelet-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Lyophilized platelet lysates
Jadi Cell Llc
December 07, 2017 - N°20170348354

The present disclosure is drawn to compositions and methods of making and using lyophilized platelet lysates. Specifically, a method of preparing a composition suitable for therapeutic use or as a culture medium can comprise steps of concentrating platelets from a platelet source to form a platelet rich portion of the platelet source, and lysing the platelets in the platelet rich ...
Red-coloured decorative pigments with high chroma and high brilliancy, method for their production and use ...
Eckart Gmbh
December 07, 2017 - N°20170348202

The present invention relates to red effect pigments including a nonmetallic substrate in platelet form and a coating applied thereto, wherein the coating includes at least one of metal oxide, metal hydroxide or metal oxide hydrate, the metal ions of the metal oxide, metal hydroxide and/or metal oxide hydrate comprise at least two different metal ions selected from the ...
Effect pigments with high chroma and high brilliancy, method for the production and use thereof
Eckart Gmbh
December 07, 2017 - N°20170348201

The invention relates to an absorbent effect pigment including a nonmetallic substrate in platelet form and a coating applied thereto, wherein the coating includes at least one spacer layer. The invention further relates to a process for production of and to the use of the absorbent effect pigment.
Platelet Patent Pack
Download 244+ patent application PDFs
Platelet Patent Applications
Download 244+ Platelet-related PDFs
For professional research & prior art discovery
inventor
  • 244+ full patent PDF documents of Platelet-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Anti-glycoprotein iib/iiia antibodies
Biogen Ma Inc.
November 30, 2017 - N°20170342152

Antibodies and antigen-binding antibody fragments that bind to gpiib/iiia and chimeric polypeptides comprising these binding molecules are disclosed. Some of these antibodies and antigen-binding antibody fragments preferentially bind gpiib/iiia on activated platelets while others do not show a preference for binding gpiib/iiia on resting versus activated platelets. Some of these antibodies and antibody fragments do not inhibit ...
Methods and compositions for delivering interleukin-1 receptor antagonist
Biomet Biologics, Llc
November 23, 2017 - N°20170334960

Methods and compositions generating and using an interleukin-1 receptor antagonist (il-1ra)-rich solution. Methods for generating and isolating interleukin-1 receptor antagonist include incubating a liquid volume of white blood cells and platelets with polyacrylamide beads to produce interleukin-1 receptor antagonist. The interleukin-1 receptor antagonist is isolated from the polyacrylamide beads to obtain the solution rich in interleukin-1 receptor antagonist. ...
Products and devices for controlling and stopping bleeding and methods of using
Cellphire, Inc.
November 23, 2017 - N°20170333593

Systems, devices, compositions, and methods for treating bleeding, for containing blood that has been lost by a subject due to bleeding, and for treating surfaces contaminated with blood or expected to be contaminated with blood are disclosed. The systems, devices, compositions, and methods utilize platelets, platelet-derived materials, or both. The invention includes sprayers, nebulizers, and equivalents, to deliver platelets and/...
Dosing regimen
Imclone, Llc
November 23, 2017 - N°20170333554

The invention provides for a dosing regimen for human antibodies that bind to human platelet-derived growth factor receptor alpha (pdgfr alpha), preferably olaratumab.
Automated microscopic cell analysis
Imclone, Llc
November 16, 2017 - N°20170328924

Disclosed in one aspect is a method for performing a complete blood count (cbc) on a sample of whole blood by metering a predetermined amount of the whole blood and mixing it with a predetermined amount of diluent and stain and transferring a portion thereof to an imaging chamber of fixed dimensions and utilizing an automated microscope with digital camera ...
Blockade of tim-1 pathways and p-selectin pathways in treatment of neuroinflammatory degenerative disease
Leuvas Therapeutics
November 16, 2017 - N°20170328919

Methods for treating, preventing and reducing the progression of neurodegenerative and neurological diseases, including, without limitation alzheimer's disease, are provided. The methods of the invention inhibit one or both of tim-1 and p-selectin function and reduce leukocyte and platelet cell adhesion, activation and interaction with the vascular endothelium and infiltration of leukocytes into the brain.
Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center
November 16, 2017 - N°20170327827

The present invention is directed to constructs, compositions and methods for modulating platelet-type 12 lipoxygenase (12-lo) in adipose tissue in vivo. Specifically, the invention provides constructs encoding expression-inhibiting oligonucleic acids, e. G. Antisense and rna interfering (rnai) molecules, targeted to a platelet-type 12-lo gene or a transcript thereof, which are capable of reducing or silencing platelet-type 12-lo expression specifically in adipocytes ...
Platelet Patent Pack
Download 244+ patent application PDFs
Platelet Patent Applications
Download 244+ Platelet-related PDFs
For professional research & prior art discovery
inventor
  • 244+ full patent PDF documents of Platelet-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Platelet lysate gel
Cell Therapy Limited
November 16, 2017 - N°20170326177

The invention concerns a pharmaceutical composition comprising a platelet lysate and its use to treat a wound, an anal fissure, vaginal atrophy or a wrinkle.
Epithelial treatment
Cell Therapy Limited
November 16, 2017 - N°20170326176

Products are described for treating epithelial tissues of the human or animal body including liquid compositions containing whole blood, or parts of blood including blood plasma, blood serum, blood platelets and growth factors derivable from blood. Other compositions disclosed include solid reservoirs of collagen or amniotic membrane into which whole blood or parts of blood have been absorbed. Methods of ...
Selective targeting of procoagulant platelets
Newsouth Innovations Pty Limited
November 16, 2017 - N°20170326096

The invention relates to a process for identifying procoagulant platelets both in vitro and in vivo, and the identification of compounds which selectively inhibit formation of procoagulant platelets.
Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent
Murray And Poole Enterprises Limited
November 16, 2017 - N°20170326083

Methods of treating and/or preventing a cardiovascular event in a patient, the method comprising orally administering a colchicine to a patient who is receiving concurrent treatment with at least one antiplatelet agent, thereby treating and/or preventing the cardiovascular event in the patient are provided.
System and method for distinguishing blood components
Labthroughput Llc
November 09, 2017 - N°20170322198

A method for measuring concentrations of blood cell components is provided. The method comprises: obtaining a blood sample from a subject, the blood sample comprising red blood cells (rbcs), white blood cells (wbcs), and platelets (plts); mixing the blood sample with a non-lysing aqueous solution to form a sample mixture comprising a predetermined tonicity; passing the sample mixture through a ...
Highly tunable colloidal perovskite nanoplatelets
Massachusetts Institute Of Technology
November 09, 2017 - N°20170321117

Colloidal perovskite nanoplatelets can provide a material platform, with tunability extending from the deep uv, across the visible, into the near-ir. The high degree of spectral tunability can be achieved through variation of the cation, metal, and halide composition as well as nanoplatelet thickness.
Administration of a selective il-6-trans-signalling inhibitor
Ferring B.v.
November 09, 2017 - N°20170320932

A selective il-6-trans-signalling inhibitor can be used to treat a variety of il-6-mediated conditions, including inflammatory diseases and cancer. The inhibitor can safely be administered to humans at a variety of doses. Moreover, the inhibitor lessens deleterious effects associated with other il-6 inhibitors such as lowering neutrophil counts, platelet counts and levels of c-reactive protein.
Function suppression type of genetically-modified rhodocytin mutant
University Of Yamanashi
November 09, 2017 - N°20170320924

According to the present invention, a mutant rhodocytin lacking platelet aggregation ability is provided. According to the present invention, a pharmaceutical composition including a mutant rhodocytin lacking platelet aggregation ability is provided. According to the present invention, there is provided a method for inhibiting platelet aggregation by a platelet aggregating substance, including administering a pharmaceutical composition including a mutant rhodocytin ...
Loading